Bending the Knowledge Curve with IBM Watson Stephen Gold, IBM Watson Solutions

© 2012 International Business Machines Corporation 2

Data is rapidly becoming the foundation for a smarter planet

Watson

© 2012 International Business Machines Corporation 3

Organizations are “dying of thirst in a sea of data”

1 in 2 business leaders

don’t have access to data they need

83% of CIOs cited BI and analytics as part of their visionary plan

2.2X more likely that top

performers use business analytics

80% of the world’s data today is unstructured

90% of the world’s

data was created in the last two

years

20% amount of data

traditional systems leverage

today

© 2012 International Business Machines Corporation 4

Big Data: This is Just the Beginning

2010

Volu

me

in E

xaby

tes

9000

8000

7000

6000

5000

4000

3000

2015

Percentage of uncertain data

Percent of uncertain data

100

80

60

40

20

0

You are here

Sensors & Devices

VoIP

Enterprise Data

Social Media

Source: IBM Global Technology Outlook - 2012

© 2012 International Business Machines Corporation 5

Brief timeline of IBM Watson

R&D

Demonstration

Commercialization

Cross-industry Applications

IBM Research Project (2006 – )

Jeopardy! Grand

Challenge (Feb 2011)

Watson for

Healthcare (Aug 2011 –)

Watson Industry Solutions (2012 – )

Watson for Financial

Services (Mar 2012 – )

Expansion

© 2012 International Business Machines Corporation 6

Watson can read these medical records in six seconds!

© 2012 International Business Machines Corporation 7

Understands natural language and human communication

Adapts and learns from user selections and responses

Generates and evaluates evidence-based hypothesis

…built on a massively parallel architecture

IBM Watson combines transformational technologies

1

2

3

© 2012 International Business Machines Corporation 8

Person Organization

L. Gerstner IBM

J. Welch GE

W. Gates Microsoft

“If leadership is an art then surely Jack Welch

has proved himself a master painter during

his tenure at GE.”

Welch ran this?

Noses that run and feet that smell? How can a house burn up as it burns down? Does CPD represent a complex comorbidity of lung cancer? What mix of zero-coupon, non-callable, A+ munis fit my risk tolerance?

Why is it so hard for computers to understand us?

© 2012 International Business Machines Corporation 9

© 2012 International Business Machines Corporation 10

These dynamics are ushering in a new era of computing

1900 1950 2011

© 2012 International Business Machines Corporation 11

Watson in Healthcare: The Art of the Possible

© 2012 International Business Machines Corporation 12

“Medicine has become too complex. Only about 20% of the knowledge clinicians use today is evidence-based.”

Steven Shapiro Chief Medical & Scientific Officer

University Pittsburgh Medical Center

Healthcare presents some formidable challenges

© 2013 IBM 13 @sgold1b

Re-imagining Medicine In 2020 Watson will change the way Medicine is:

RESEARCHED •MD Anderson’s Moon Shot program

PRACTICED •Memorial Sloan-Kettering, Community Cancer Care Centers

TAUGHT •Students learning from and “teaching” Watson at the Cleveland Clinic

© 2013 IBM 14 @manojsaxena

Baby boomers retire daily

Active Facebook, Twitter, and YouTube accounts

% top performers integrating analytics for

better insights

Mobile devices world-wide; 1B+ of them smartphones

What’s next for Watson?

“You don’t know me” Intolerance of mass-market, impersonalized approaches

“It’s too hard” Need the right information in the

right place at the right time

“You’re not connecting with me” Social / mobile replacing PC/web for quick, easy answers but 75% of self-service fails

© 2012 International Business Machines Corporation 15

IBM Watson is also positioned to transform client engagement

© 2012 International Business Machines Corporation 16

The opportunities for transformation are nearly endless

© 2012 International Business Machines Corporation 17

© 2012 International Business Machines Corporation 18

IBM, the IBM logo, ibm.com, DB2, POWER, Power7, and Storwize are trademarks of International Business Machines Corp., registered in many jurisdictions worldwide. Java and all Java-based trademarks and logos are trademarks or registered trademarks of Oracle and/or its affiliates. Other company, product and service names might be trademarks of IBM or other companies. A current list of IBM trademarks is available on the Web at "Copyright and trademark information" at www.ibm.com/legal/copytrade.shtml. All information contained in this document is subject to change without notice. The client examples described are presented as illustrations of how those clients have used IBM products and the results they may have achieved. Actual environmental costs and performance characteristics may vary by client. Information concerning non-IBM products was obtained from a supplier of these products, published announcement material, or other publicly available sources and does not constitute an endorsement of such products by IBM. Sources for non-IBM list prices are taken from publicly available information, including vendor announcements and vendor worldwide webpages. Questions on the capability of non-IBM products should be addressed to the supplier of those products. All statements regarding IBM future direction and intent are subject to change or withdrawal without notice, and represent goals and objectives only. The actual performance that any user will experience will vary depending upon considerations such as the amount of multiprogramming in the user's job stream, the I/O configuration, the storage configuration, and the workload processed. Therefore, no assurance can be given that an individual user will achieve throughput or performance improvements equivalent to the ratios stated here. Starting price may not include a hard drive, operating system or other features. Prices are subject to change without notice. Contact your IBM representative or Business Partner for the most current pricing in your geography. The products described in this document are NOT intended for use in implantation, life support, space, nuclear, or military applications where malfunction may result in injury or death to persons. The information contained in this document does not affect or change IBM product specifications or warranties. Nothing in this document shall operate as an express or implied license or indemnity under the intellectual property rights of IBM or third parties. THE INFORMATION CONTAINED IN THIS DOCUMENT IS PROVIDED ON AN “AS IS” BASIS WITHOUT WARRANTY OR CONDITION OF ANY KIND, WHETHER EXPRESS OR IMPLIED. In no event will IBM be liable for damages arising directly or indirectly from any use of the information contained in this document. References in this document to IBM products or services do not imply that IBM intends to make them available in every country. © IBM Corporation 2012. All rights reserved. 11/15/11